The effective refractory period of the right ventricle (ERP-V) was measured in 27 patients during atrial or ventricular pacing using the ventricular extra stimulus method. Pacing was conducted with impulses of 1.5-2 times diastolic threshold. The ERP-V was directly related to the basic cycle length (BCL) although the ERP-V was always greater for atrial pacing than for ventricular pacing at a given BCL. The ratio ERP-V/BCL was greater at shorter cycle lengths indicating that a larger fraction of the cycle was refractory at faster heart rates. The ratio ERP-V/QT interval did not change over a range of BCLs, but the ratio was larger for atrial pacing (.77 ±.05 SD) than for ventricular pacing (.60±
REFRACTORINESS is a fundamental electrophysiological characteristic of the human heart and has been measured for the right atrium, A-V node, and ventricular specialized conduction tissues.' In this study we report an evaluation of the effective refractory period of the ventricular myocardium and of some of the variables which affect this function.
Materials and Methods Number 6 and 7 quadripolar electrode catheters were introduced percutaneously or by cutdown through femoral or antecubital veins and advanced under fluoroscopic control to the right atrium (RA), right ventricular apex (RVA) and right ventricular outflow tract (IRVOT). Diastolic threshold for pacing was established as the minimal current required to capture the atrium or ventricle during constant pacing. Studies were then conducted with impulses of one msec width and 1.5-2 times diastolic threshold (in one patient, up to 16 times diastolic threshold).
Paced basic cycle lengths (BCL) between 450 and 1000 msec were established from either RA, RVA or RVOT. Premature beats were introduced every 8-12 beats into the RVA at progressively shorter coupling intervals. In five patients, BCLs and premature depolarizations were also introduced at different locations: 1) BCL at RVA with premature beats at the RVOT; 2) BCL at RVOT with premature beats at the RVA; 3) BCL at the RVOT with premature beats at the RVOT. 450 .05). Atropine (1 mg i.v.) was given to six patients. The drug did not affect the ERP-V in six of eleven determinations, prolonged ERP-V twice and shortened it slightly three times. Measurements were reproducible over an hour but varied at a given BCL when measured on separate days. Asymptomatic repetitive beating occurred in seven of 27 patients when the premature stimulus was within 20 msec of the ERP-V.
The effective refractory period of the right ventricle in man can be determined reproducibly and with safety. Changes induced by various perturbations parallel results from in vitro single cell and myocardial studies.
Electrocardiographic signals were amplified in an Electronics for Medicine DR-16 recorder with filter settings of 40-500 Hz for the intracardiac electrograms and displayed on photographic paper at 100 or 200 mm/sec. Surface leads I, II, aVF and V1 were simultaneously monitored. Pacing impulses were generated by a digitally programmed stimulator (Bloom Associates, Ltd., Narberth, Pennsylvania).
The various deflections and measurements were defined as follows:
Slthe stimulus artifact of a paced basic cycle beat. Vthe ventricular depolarization of a basic cycle beat, whether spontaneous or paced. S2 -the stimulus artifact of a paced ventricular premature beat.
V2 -the ventricular depolarization of the ventricular premature beat.
Vl-S2 -the coupling interval between the ventricular depolarization of a basic cycle beat and the stimulus artifact of the following premature ventricular beat.
Effective refractory period of the right ventricle (ERP-V) during sinus rhythm or when BCL was established in the RA the longest V l-S2 interval where capture by the premature stimulus (S2) fails2 ( fig. 1 ).
Effective refractory period of the right ventricle (ERP-V) when BCL was established in the right ventriclethe longest S1-S2 interval where capture by S2 fails ( fig. 1 ).
Patients
The ERP-V was measured in 27 patients during a scheduled cardiac catheterization performed for diagnostic purposes after informed consent was obtained. There were 20 males and seven females ranging in age between 19 and 80 years (mean age 52 years). Ten patients had atherosclerotic coronary artery disease, three had complete heart block, four had conduction defects, one was hypertensive, two had mitral valve disease, one had sinus bradycardia, and six were found to have no cardiac disease.
The ERP-V was measured during RVA pacing in 23 patients. In addition, the ERP-V was measured during the intrinsic cardiac rhythm in nine patients (seven in sinus rhythm, two in complete heart block) and during atrial pac- ing in 13 patients. Most patients had the ERP-V determined at several paced BCLs. The ERP-V was also measured before and 20 minutes after the intravenous administration of 1 mg of atropine sulfate in six patients.
Results

Effects of Cycle Length
In each patient the ERP-V decreased at shorter BCLs (faster rates) (tables 1 and 2, fig. 2 ). With ventricular pacing at a BCL of 600 msec the mean ERP-V was 240 msec ± 6 (SE) in 16 patients; whereas, at a BCL of 500 msec, the mean ERP-V was 232 ± 5 msec in 15 patients tested at that paced heart rate. This relationship was present whether the patient was paced from the RA or RVA.
Linear regression analysis of the relationship of ERP-V to BCL showed, as visualized on the graph in figure 2, that the slopes were not zero for both atrial (P < 0.02) and ventricular (P < 0.01) pacing. Thus the ERP-V was directly related to the BCL whether established in the RA or RVA.
In two patients with complete heart block the ventricular ERPs were also determined when these patients were in their intrinsic idioventricular escape rhythms. In patient B.B. the escape interval was 1320 msec and the ERP was 330 msec. Her escape beats had the appearance of left bundle branch block which is presumed to indicate that the focus was in the right ventricle. Patient W.K.'s complete heart block had appeared seven years earlier, after surgical repair of atrial and ventricular septal defects. His escape interval was 1220 msec and the ventricular ERP was 330 msec. The QRS complexes had the appearance of right bundle branch block (presumed left ventricular origin).
The ratio ERP-V/BCL increased in each patient as the BCL shortened ( fig. 3 ), consistent with the suggestion that a greater portion of the cardiac cycle was refractory at faster than at slower rates.
Effects of Pacing Location
The mean ERP-V was longer when pacing was established in the RA than in the RVA at the same BCL (tables 1 and 2, fig. 2 ). Thus, at a BCL of 600 msec, for example, the mean ERP-V was 284 ± 5 msec with atrial pacing (8 Abbreviations: WNL = within normal limits; MVD = mitral valve disease; CAD = coronary artery disease; CHB = complete heart block; RBBB = right bundle branch block; LBBB = left bundle branch block; HT = hypertension; IVCD = interventricular conduction defect. 240 ± 6 msec with ventricular pacing (16 patients). In each of seven patients where direct paired comparisons were made at the same BCL, the ERP-V was always longer with RA pacing than with RV pacing.
Linear regression analysis revealed that the slopes of the two relationships of ERP-V and BCL from RA or RVA pacing were not statistically different from each other but did intercept the ERP-V axis at different points ( fig. 2 ). The ventricular effective refractory periods for atrial and ventricular pacing were different at each BCL tested and changed at a constant increment at each pacing location as the BCL was changed.
Relationship of ERP-V and QT Interval
The QT interval as well as the ERP-V decreased in all 27 patients as BCL was shortened (faster rates) ( fig. 2) . The ERP-V, without exception, occurred on the upslope of the T wave during ventricular pacing (BCL and premature beats at the same ventricular site), and on the downslope of the T wave during RA pacing ( fig. 1 ). The ratio ERP-V/QT was constant in each patient regardless of rate, but was greater with atrial pacing (0.77 ± .05 in 43 determinations) than with ventricular pacing (0.60 ± .05 in 83 determinations, P < 0.0001, fig. 4 and table 3 ).
Effects of Pacing BCL and Premature Beats at Different Sites
In five patients the ERP-V was measured at both the RVA and RVOT (table 4 ). (1) The ERP-V for pacing BCL at the RVA with premature beats at the RVA was equal to the ERP-V for pacing BCL at the RVOT with premature beats at the RVOT (patients E.L. and J.W.). (2) The ERP-V for pacing BCL at the RVA with premature beats at the RVOT was nearly equal (within 5 msec) to the ERP-V for pacing BCL from the RVOT with premature beats at the RVA (patients E.L. and J.W.). (3) The ERP-V in statement 1 was shorter than the ERP-V in statement 2 as follows: 60 and 55 msec in patient R.A.; 55 msec in patient M.H.; 55 and 60 msec in patient E.L.; 70 msec in patient E.C.; 95 and 100 msec in patient J.W.
Effects of Atropine
Six patients were given 1 mg of atropine intravenously, and the ERP-V during ventricular or atrial pacing was determined before and 20 minutes after injections (table 5) . Eleven determinations were made in the six patients. In six tests there was no change at the same basic cycle lengths. Twice the ERP-V increased after atropine (25 msec at BCL 600 msec in patient J.F. and 20 msec at BCL 550 msec in patient J.M.) and on three occasions the ERP-V decreased slightly after atropine (5 msec at BCL 450 msec in patient J.M.; 10 msec at BCL 500 msec in patient C.S.; and 5 msec at BCL 450 msec in patient W.S.).
Reproducibility
The ERP-V varied no more than 5 msec when determined several times in a 20 minute period. However, when the determination was repeated in two patients on two separate occasions two weeks and three months apart, the ERP-V at the same BCL was 20 and 35 msec different.
Repetitive Beating
In six of 27 patients, one or two spontaneous ventricular beats developed after the paced ventricular premature beat (V2). In a seventh patient, a burst of eight consecutive ventricular premature beats followed V2 but spontaneously ter- Repetitive beating occurred only when the S1-S2 interval was within 20 msec of the ERP-V.
Discussion
Measurement of ERP-V
The effective refractory period is that interval of time during which a propagated action potential cannot be evoked by an appropriate stimulus and conducted through the structure under study.3 This value is not a point in time although it is determined as such. Since refractoriness is being measured, it seems more appropriate to us that this interval, the ERP-V, be terminated at the latest point where depolarization cannot be accomplished rather than at that instant when activation is first possible.
The ERP-V may be affected by sudden changes in heart rate, and the BCL must be established for several minutes before a steady state is reached.4 In this study, patients were paced for several minutes at each rate before determination was made of the ERP-V. Our results should not be influenced by this consideration.
Basic Cycle Length
Our data on the refractoriness of the human ventricle demonstrate the same inverse relationship between heart rate and ERP-V that has been previously recognized in animals.5' B Recently, this same relationship has been shown in the atria, bundle branches and His-Purkinje system of man.'
Our data suggest that the human ventricle is refractory for a longer portion of the inter-beat cycle at faster rates than at slower rates. This electrophysiologic characteristic correlates with the hemodynamic observation that systole occupies a greater portion of the cycle as the heart rate increases. Both the ERP-V and QT intervals decreased at shorter BCLs. The amount of QT interval change was found to be equal to the change in ERP-V at every BCL induced in these studies; therefore, the ratio ERP-V/QT remained constant at different rates.
The QT interval in the electrocardiogram is thought to reflect the sum of the action potential durations of all ventricular muscle cells. At faster rates the action potential duration shortens, like the QT interval. The fixed relationship of the ERP-V to the QT interval at various rates suggests that the effects of pharmacologic interventions on this parameter (ERP-V/QT) at different BCLs are comparable. Increases in the ratio ERP-V/action potential duration have been observed when anti-arrhythmic drugs are administered, and have been suggested to be an important feature of the effectiveness of such drugs.7 Preliminary studies in patients support some of these in vitro findings.8
Site of Pacing
At the same rate the ERP-V was always longer when the basic cycle length was established in the RA rather than at the RVA where the testing premature stimuli were also introduced. The ERP-V bore a constant relationship to the T wave, occurring on the upslope of the T wave for ventricular pacing and on the downslope of the T wave for atrial pacing or sinus rhythm in lead V1.
There are at least two possible explanations for this finding. The RVA is depolarized 18 ± 9 msec after the onset of the QRS in patients without conduction disturbances.9 The RVA will, presumably, be refractory for 20 msec longer after onset of QRS during normal atrioventricular conduction than when the RVA is the first part of the heart to be activated as when the BCL is established from there. However, the observed differences of 35-45 msec cannot be adequately explained by this mechanism alone. Recent information from our colleagues suggests that a portion of the remaining difference can be explained by the local electrophysiologic effects of the current applied at the test site for establishment of the BCL.'0 Preliminary data collected in the canine model demonstrate that refrac-toriness is shortened in such cases.
Our studies further establish that tissues in at least two different locations within the right ventricle, the apex and outflow tract, have the same ERP-V as long as the BCL and test stimuli are applied at the same location. Yet to be determined is whether the ERP-V will be different when measurements are made from multiple sites within both ventricles or when cardiac pathology is present.
The longer ERP-V measured when the BCL was established at the apex or outflow tract and the ERP-V determined at the other site can be explained in part by the conduction times from the RVA to RVOT. Similar conduction times between RVA and RVOT have been found in other studies.9' 11, 12 Effect of Atropine Parasympathetic blockade with atropine had little effect on the ERP-V in most of our studies. This finding is consistent with the observation that neither vagal stimulation nor administration of acetylcholine influence the ERP-V of the canine ventricle.', 13 14 The effect of sympathetic stimulation on the ERP-V in man has yet to be reported.
Individual ERP-V Variations
We analyzed the range of refractory periods in an effort to correlate the values with some aspect of the patient's clinical state or age. No consistent pattern emerged.
Latency and the Strength-Interval Curve
The measurement of relative refractoriness in cardiac muscle can be considered from two aspects: latency and the strength-interval curve. As the test intervals are shortening near the effective refractory period, conduction in the tissues surrounding the electrode slows. A period of latency is observed which can be demonstrated as an increasing time from the stimulus to the response. This property was not measured directly in our study. To have done so would have required the presence of additional sensing electrodes in the right ventricle. We examined our surface electrocardiographic records to see whether an interval from pacing stimulus to beginning of the QRS complex could be measured as an indirect reflection of latency. Unfortunately, the surface ECG did not allow such measurements to be made in most cases. The stimulus artifact "slurs" into the beginning of the QRS complex and thus hides this interval.
In animals a strength-interval curve can be constructed which shows that with increasing amounts of pacing power, the refractory period shortens. However, for a rather broad range of increases in current, only a slight change in refractoriness was noted in three patients, in whom we changed the current from 2.5 to 6 mA (1.5-16 times diastolic threshold). Measurements were made across a resistor in series with the electrodes and stimulator. No change in refractoriness was observed. The results suggest that twice threshold current used in our patients was on the "vertical limb" of the strength-interval curve. In order to reduce variations in refractoriness during the course of a study no changes were made in the stimulator settings for current or pulse duration and the catheters were not moved, except in the studies of the strength-interval curves. 454 CIRCULATION VENTRICULAR REFRACTORINESS/Guss, Kastor, Josephson, Scharf Reproducibility The human ventricular ERP-V does not change when rate, site of stimulation, electrode myocardial interface, and the stimulus strength are kept constant over the course of about one hour. Under these circumstances, the changes in ERP-V produced by administration of drugs can be accurately measured. However, we found that when the study was repeated weeks later, the ERP-V displayed variations (20-25 msec). Until these variations can be eliminated, repeat studies over periods of time may not be comparable.
Repetitive Beating
In some patients spontaneous ventricular beats followed the test stimulus when the BCL was established in the ventricle. The appearance of repetitive beating was independent of the stimulus strength, occurring at all ranges between 1.5 and 16 times diastolic threshold. The single patient with a short run of ventricular tachycardia (eight beats with spontaneous termination), remained asymptomatic. Similar observations have been made previously, 15 16 but the clinical significance of these findings is unknown.
These studies demonstrate the safety of studying the ERP-V in humans using the ventricular extrastimulus method. This technique should facilitate the study of ventricular refractoriness in patients and the effects of drugs on modifying ventricular excitability.
